Emily B Carter
Overview
Explore the profile of Emily B Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nersesian S, Carter E, Lee S, Westhaver L, Boudreau J
Front Immunol
. 2023 Dec;
14:1269614.
PMID: 38090565
Natural killer (NK) cells integrate heterogeneous signals for activation and inhibition using germline-encoded receptors. These receptors are stochastically co-expressed, and their concurrent engagement and signaling can adjust the sensitivity of...
2.
Carter E, Pugh-Toole M, Kabil A, Boudreau J, Nersesian S
J Leukoc Biol
. 2023 Feb;
114(1):79-83.
PMID: 36805942
The Canadian Society for Immunology 2022 Annual Meeting (June 17-20, 2022) brought together immunologists from across the country to discuss current topics and cutting-edge research in immunology. Here we highlight...
3.
Westhaver L, Nersesian S, Nelson A, MacLean L, Carter E, Boudreau J
STAR Protoc
. 2022 Oct;
3(4):101738.
PMID: 36183256
Mitochondrial damage-associated molecular patterns (mitoDAMPs) are released from cells dying uncontrolled, non-apoptotic deaths, usually secondary to disease or trauma. Here, we describe preparation of mitoDAMPs from mouse liver, but this...
4.
Westhaver L, Nersesian S, Nelson A, MacLean L, Carter E, Rowter D, et al.
Cell Rep
. 2022 May;
39(8):110847.
PMID: 35613582
Tissue damage leads to loss of cellular and mitochondrial membrane integrity and release of damage-associated molecular patterns, including those of mitochondrial origin (mitoDAMPs). Here, we describe the lymphocyte response to...